A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022

A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022 Publisher

Mehrizi TZ¹ ; Ardestani MS² ; Rezayat SM³ ; Javanmard A⁴

Show Affiliations

1. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2. Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Cancer and Nutrition Researcher, Department of Nutrition, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Nanomedicine Journal Published:2023

Abstract

Due to the unique properties of chitosan (antibacterial and stimulating tissue repair factors) in improving cell function, modified chitosan derivatives are widely used to improve the function of blood products. However, interaction of chitosan positive surface charge with negatively charged blood cells and anionic proteins, increases hemolysis, platelet activation, and dysfunction of plasma proteins, so the use of chitosan in blood applications requires surface modifications. Therefore, in this review study, we review the literature (2010–2022) to determine whether the charged-modified chitosan could eliminate the effects of chitosan on blood products and prepare a platform for more research to improve the preservation of the blood products such as erythrocytes, platelets and plasma proteins (albumin, immunoglobulin (Ig) and factor (FVIII)). Overall, the results of this review study show that negative surface-charged chitosan can increase hematopoiesis and increase the preservation of erythrocytes, platelet, and plasma products. Modified chitosan can be used as an anticoagulant compound for purification and filtration of plasma proteins, gene transfer of FVIII, and to increase the stability of plasma proteins. In addition, due to its antibacterial and hemostatic properties, negatively charged chitosan can stimulate coagulation factors and rapid wound healing and can be used in the production of wound dressings. This review study provides researchers with a new insight into the effectiveness of negative-charged chitosan in improving the preservation of blood products including erythrocytes, platelets, and plasma products (albumin, immunoglobulin, and FVIII) and promises to increase the efficacy of negative-charged chitosan in the future research. © 2023 Laura Barrera-Jerez.

Related Docs

View other Related Docs

1. A Review Study on the Application of Polymeric-Based Nanoparticles As a Novel Approach for Enhancing the Stability of Albumins, Nanomedicine Journal (2022)

2. Advances in Nanotechnology for Improving the Targeted Delivery and Activity of Amphotericin B (2011–2023): A Systematic Review, Nanotoxicology (2024)

3. The Introduction of Dendrimers As a New Approach to Improve the Performance and Quality of Various Blood Products (Platelets, Plasma and Erythrocytes): A 2010-2022 Review Study, Current Nanoscience (2023)

4. Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021, Current Pharmaceutical Biotechnology (2024)

5. A Review of the Use of Metallic Nanoparticles As a Novel Approach for Overcoming the Stability Challenges of Blood Products: A Narrative Review From 2011-2021, Current Drug Delivery (2023)

6. Application of Non-Metal Nanoparticles, As a Novel Approach, for Improving the Stability of Blood Products: 2011–2021, Progress in Biomaterials (2022)

7. A Novel Nanoformulation for Reducing the Toxicity and Increasing the Efficacy of Betulinic Acid Using Anionic Linear Globular Dendrimer, Journal of Nanostructures (2021)

8. A Review Study About the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania From 2010 to 2020, Current Drug Delivery (2021)

Experts (# of related papers)

View all Related Experts

Mehdi Shafee Ardestani (11)

Seyed Mahdi Rezayat Sorkhabadi (2)

Style	Citing Format
MLA	Mehrizi TZ, et al.. "A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022." Nanomedicine Journal, vol. 10, no. 1, 2023, pp. 16-32.
APA	Mehrizi TZ, Ardestani MS, Rezayat SM, Javanmard A (2023). A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022. Nanomedicine Journal, 10(1), 16-32.
Chicago	Mehrizi TZ, Ardestani MS, Rezayat SM, Javanmard A. "A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022." Nanomedicine Journal 10, no. 1 (2023): 16-32.
Harvard	Mehrizi TZ et al. (2023) 'A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022', Nanomedicine Journal, 10(1), pp. 16-32.
Vancouver	Mehrizi TZ, Ardestani MS, Rezayat SM, Javanmard A. A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022. Nanomedicine Journal. 2023;10(1):16-32.
BibTex	@article{ author = {Mehrizi TZ and Ardestani MS and Rezayat SM and Javanmard A}, title = {A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022}, journal = {Nanomedicine Journal}, volume = {10}, number = {1}, pages = {16-32}, year = {2023} }
RIS	TY - JOUR AU - Mehrizi TZ AU - Ardestani MS AU - Rezayat SM AU - Javanmard A TI - A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022 JO - Nanomedicine Journal VL - 10 IS - 1 SP - 16 EP - 32 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract